WORK GROUP REGULATORY


GOAL: implementation and reimbursement of liquid biopsy assays in routine clinical practice.

  • Exchange with regulatory agencies (e.g. EMA, FDA) and health care providers
  • Acquire knowledge on regulatory terms and conditions
  • Collect input by health care providers
  • Represent a liaison between the ELBS members and regulatory bodies